Evidence map›Paper›PMID 42818657›Full record

ArticlebioRxiv : the preprint server for biology2026

RNA-aware tissue preservation workflows for high-quality spatial transcriptomics.

Paolo Cadinu, Christian A Reardon-Lochbaum, Hao Zhang, Katerina Kalemaki, Brianna R Watson, Stelios Smirnakis, Scott B Snapper, Alan B Cantor, Jeffrey R Moffitt

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paolo CadinuProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Christian A Reardon-LochbaumProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Hao ZhangProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Katerina KalemakiDivisions of Stroke, Cerebrovascular, and Critical Care Neurology, Department of Neurology, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
Brianna R WatsonProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Stelios SmirnakisDivisions of Stroke, Cerebrovascular, and Critical Care Neurology, Department of Neurology, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
Scott B SnapperDivision of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Alan B CantorHarvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
Jeffrey R MoffittProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0002-3836-3101

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI Irene M. Ghobrial · 1985 to 2026
$330.6M
STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JONATHAN C KAGAN · 1986 to 2026
$32.4M
PATHOPHYSIOLOGY OF HUMAN BLOOD CELLST32HL007574 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI Daniel Evan Bauer · 1985 to 2026
$18.4M
Dense Analysis of Cortical Circuit Dysfunction in the MECP2-duplication Syndrome of AutismR01NS113890 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI SMIRNAKIS, STELIOS MANOLIS · 2021 to 2025
$3.3M
Rapid, Robust, and Routine: Multiplexed Microscopy for Spatially Resolved Whole-Transcriptomic Single-Cell Profiling and the Construction of Cell Atlases of all Tissues and in all OrganismsR01GM143277 · NIGMS · BOSTON CHILDREN'S HOSPITAL · PI MOFFITT, JEFFREY · 2021 to 2024
$1.6M
Bone Marrow Spatial Transcriptomics to Enhance In Vitro Platelet ProductionR01HL159106 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI CANTOR, ALAN B. · 2021 to 2023
$1.1M
BLRD VA I01 BX006131NCI NIH HHS P30 CA006516NHLBI NIH HHS R01 HL159106NHLBI NIH HHS T32 HL007574NIDDK NIH HHS P30 DK034854NIGMS NIH HHS R01 GM143277NINDS NIH HHS R01 NS113890
6 · The paper itself

Abstract

Image-based transcriptomic approaches can define, discover, and chart cell types and states within an array of tissues. However, measurement quality depends on RNA integrity, and the modern tissue preservation toolbox was not designed to protect this highly labile molecule. Here we leverage MERFISH to show that tissue-dependent differences in endogenous RNase activity can shape spatial transcriptomics data quality for different preservation methods and that RNase-activity-guided protocol optimization can improve data quality. In parallel, we introduce an RNA-aware pan-tissue preservation approach, Rapid Inhibition and Permanent Inactivation of Nucleases (RIPIN), that rapidly stabilizes samples with a broad-spectrum RNase inhibitor while permitting slow, chemical inactivation. RIPIN produces high-quality MERFISH measurements in all profiled human and mouse tissues, is compatible with clinical workflows, and is easily integrated with frozen or paraffin sectioning. By highlighting how RNA integrity can be lost during tissue processing, our work may inspire the next generation of RNA-aware histology methods.

Identifiers

PMID42818657
PMCPMC13622580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.